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Abstract
Introduction: Intervertebral disc tissue homeostasis is modulated by a variety of molecules. Silent mating type
information regulator 2 homolog 1 (SIRT1) plays a key role in various physiological processes. The aim of the
present study was to verify the expression of SIRT1 and determine SIRT1 function in human intervertebral disc cell
homeostasis.
Methods: Human nucleus pulposus (NP) cells were obtained from 24 surgical patients (mean age: 39.4 years) and
monolayer-cultured. SIRT1 expression was investigated using RT-PCR analysis and immunohistochemical staining.
Quantitative real-time RT-PCR was performed to detect mRNA expression of SIRT1 and other genes: aggrecan,
collagen type 2 and Sox9. The effect of SIRT1 on the extracellular matrix metabolism of NP cells was examined
using recombinant human SIRT1 protein and a protein delivery reagent. Cell number and proliferation activity were
measured following SIRT1 treatment. To reveal the deacetylation potential of transfected recombinant human
SIRT1, western blotting for acetylated p53 was utilized. R-phycoerythrin was used for the negative control.
Results: SIRT1 expression was confirmed at both mRNA and protein levels in almost all NP cells. Real-time RT-PCR
analysis showed SIRT1 mRNA expression significantly increased with donor age (P< 0.05, r = 0.492). Pfirrmann
grade 3 discs showed significantly higher SIRT1 mRNA expression than other grades. SIRT1 treatment significantly
reduced aggrecan, Sox9 and collagen type 2 mRNA expression in a dose-dependent manner in all disease classes
and disc degeneration grades. Proliferation activity was decreased by SIRT1 treatment in lumbar spinal stenosis and
lumbar disc herniation, Pfirrmann grade 3 and grade 4 discs. In contrast, it was significantly upregulated in
idiopathic scoliosis, Pfirrmann grade 2 discs. The negative control protein did not affect extracellular matrix
metabolism or proliferation activity.
Conclusions: We demonstrate for the first time that SIRT1 is expressed by human NP cells. SIRT1 expression was
significantly elevated in an early degeneration stage. SIRT1 affected both extracellular matrix metabolism and
proliferation activity; the effect of SIRT1 was altered according to disease class and disc degeneration grade. SIRT1
appears to play a key role in homeostasis during the human intervertebral disc degeneration process.
Introduction
The high morbidity of low back pain causes severe inca-
pacity that increases medical expenses and impacts the
workforce, resulting in high socioeconomic costs. Effec-
tive treatment of low back pain is therefore a matter of
great public concern [1]. Although the exact
pathomechanism of low back pain remains poorly
understood, intervertebral disc (IVD) degeneration is
thought to be a major cause [2]. Structurally, the IVD is
an avascular tissue composed of an inner nucleus pulpo-
sus (NP) surrounded by an outer annulus fibrosus (AF),
and sandwiched between the cartilaginous endplates of
contiguous vertebral bodies. The NP cell environment is
characterized by low nutrition levels, oxygen tension
* Correspondence: kakutani@med.kobe-u.ac.jp
Department of Orthopaedic Surgery, Kobe University Graduate School of
Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Japan 650-0017
Zhang et al. Arthritis Research & Therapy 2011, 13:R200
http://arthritis-research.com/content/13/6/R200
© 2011 Zhang et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.and pH, dependent upon diffusion across the AF and
cartilaginous endplates [3-5].
IVD degeneration is considered to be a mechanically-
induced and biologically-mediated pathological condi-
tion, often found concurrent with aging. With degenera-
tion and aging, disc cells undergo substantial biological
changes, including alterations in cell type, density, pro-
liferation activity and phenotype, characterized by a
compromised capability to synthesize normal matrix
components and enhanced catabolic metabolism [6].
Polypeptide growth factors, such as insulin-like growth
factor-1, transforming growth factor beta, and the bone
morphogenetic proteins, play important roles in anabolic
regulation of the IVD [7,8]. The IVD is known to
express cytokines, including IL-1 and TNFa [9,10]. Dur-
ing aging and degeneration, the IVD undergoes exten-
sive histomorphological changes, including fibrosis of
the NP, disorganization of the AF lamellae, and thinning
and calcification of the cartilaginous endplates; this
results in deterioration of the IVD nutrient supply,
adversely affecting disc cell viability [11,12]. Nutrient
reduction for IVD cells has a powerful effect on IVD
degeneration [13]. The healthy IVD is avascular, being
supplied with nutrition and oxygen through passive dif-
fusion [13]; while in the degenerating IVD, nutritional
diffusion is inhibited by calcification of the endplates
[14,15] and reduced blood supply from the vertebral
body [16]. These changes result in decreased extracellu-
lar matrix production and increased cell apoptosis. To
fully comprehend IVD degenerat i o n ,i ti st h u se s s e n t i a l
to determine the response of IVD cell mechanisms to
reduced nutritional status and increased hypoxic
conditions.
Silent information regulator 2 protein (sirtuin) is a
group of nicotinamide (NAD
+)-dependent deacetylases/
ADP-ribosyltransferases initially discovered in yeast. A
human homolog of silent information regulator 2, silent
mating type information regulator 2 homolog 1 (SIRT1),
has been reported to play a key role in transcriptional
silencing, genome stability and extended lifespan follow-
ing calorie restriction because of its ability to deacetylate
both histone and nonhistone substrates, such as p53,
NF-B, forkhead box type O-3, and peroxisome prolif-
erator-activated receptor-g coactivator-1a [17,18].
SIRT1 is crucial in the pathophysiology of metabolic
disease, neurodegenerative disorders, cancer, and aging
[17,19]. Although the expression of SIRT1 in human
IVD cells has not yet been established, SIRT1 has
recently been found to be expressed by human chondro-
cytes and to play a key role in chondrocyte survival by
regulating apoptosis, findings that could be important in
the pathogenesis of osteoarthritis [20,21]. SIRT1 has
also been reported to play a positive role in regulation
of the expression of the cartilage-specific gene, Sox9,i n
human chondrocytes [22].
Calorie restriction was considered to be a potent indu-
cer of SIRT1 protein expression in humans and rodents
[23] and, additionally, SIRT1 levels were elevated by glu-
cose starvation [23]. Because IVD cells must survive the
harsh environmental conditions of low nutritional sup-
ply, low oxygen tension and low pH, the IVD environ-
ment is one of glucose starvation with calorie
restriction. We therefore hypothesize that SIRT1 is
expressed by human IVD cells to enhance survival in
this harsh environment, and plays an important role in
IVD cell homeostasis. The aims of the present study
were to verify the expression of SIRT1 by human IVD
cells, to elucidate the function of SIRT1 in IVD cell
homeostasis, and to examine the relationship of SIRT1
to disc degeneration.
Materials and methods
The collection and use of human disc specimens for the
present study were approved by the ethics committee of
Kobe University Hospital.
Patients and specimens
Human NP tissues were obtained from 24 consented
patients undergoing surgical procedures for lumbar
spinal stenosis (LSS; n = 8), lumbar disc herniation
(LDH, n = 6), or idiopathic scoliosis (n =1 0 ) .T h e r e
were nine men and 15 women with a mean age of 39.4
years (range: 13 to 76 years). Written informed consent
was obtained from all tissue donors before surgery. The
degree of IVD degeneration was evaluated using preo-
perative magnetic resonance imaging (MRI) according
to the Pfirrmann grading system, from grade 1 (normal)
through grade 5 (severe degeneration) [24].
The NP was isolated after the outermost layer of the
AF (about 0.5 mm) was dissected and discarded to pre-
vent contamination with cells from surrounding liga-
m e n t s .T h et i s s u es a m p l e sw e re first collected from the
center portion of the NP and then underwent sequential
enzyme digestion at 37°C with 0.025% collagenase P
(Roche Applied Science, Indianapolis, IN, USA) and
0.001% deoxy-ribonuclease 2 (DNase 2; Sigma-Aldrich,
St Louis, MO, USA) for 12 hours in 5% carbon dioxide
and 95% air. The digested NP tissues were placed in
complete tissue culture media, DMEM (Sigma-Aldrich)
supplemented with 10% heat-inactivated fetal bovine
serum (Sigma-Aldrich), 100 U/ml penicillin, and 100
mg/ml streptomycin. The cells were released from their
matrix by centrifugation at 230 × g and placed in 35
mm tissue culture dishes in 5% carbon dioxide and 95%
air for 3 days of preculture. For the present study, these
isolated cells are defined as NP cells.
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Total cellular RNA was isolated from NP cells using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) according
to the manufacturer’s instructions. Reverse transcription
to cDNA used 1 μg total RNA in the presence of oligo
d(T) primer (Applied Biosystems, Foster City, CA,
USA). The mixture was incubated at 75°C for 5 minutes
and 37°C for 120 minutes.
For analysis we used 20 μlo ft h eP C Rm i x t u r e ,c o n -
taining 1 μl cDNA reaction product, 2 mmol/l dNTP
mix, 10× PCR buffer, 25 mmol/l MgCl2,5U / μl Ampli
T a qG o l d( A p p l i e dB i o s y s t e m s ) ,a n d1μmol/l primers.
Predesigned primers were used for SIRT1 (HA044263;
Takarabio, Tokyo, Japan), a2-macroglobulin
(HA107564; Takarabio), cytokeratin-18 (HA138837;
Takarabio) and CD56 (HA106134; Takarabio) [25].
The PCR production consisted of 35 cycles of denatur-
ing at 95°C for 1 minute, annealing at 53°C for 1 min-
ute, and extension at 72°C for 1 minute. PCR products
were separated by electrophoresis in 2% agarose gels.
The gels were visualized using the LAS-3000 UV mini
(FUJIFILM, Tokyo, Japan). The primer sequences are
presented in Table 1.
Real-time RT-PCR analysis
The cDNA was amplified using the ABI Prism 7500
sequence detection system (Applied Biosystems). RT
products were subjected to real-time PCR with the Per-
fect Real Time SYBR Premix Ex Taq™ (RR041A; Takar-
abio). Predesigned primers were used for SIRT1,
aggrecan (HA069617; Takarabio), Sox9 (HA117773;
Takarabio), collagen type 2 (HA098861; Takarabio), and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(HA067812; Takarabio). The total 20 μl volume of reac-
tion mixture contained 10 μlS Y B RG r e e nM i x ,0 . 4μl
ROX dye, 6.8 μl RNase-free H2O, 0.8 μl primer mix and
2 μl cDNA. This PCR procedure ran for 55 denaturing
cycles at 95°C for 5 minutes, then annealing and exten-
sion at 60°C for 34 seconds, according to the manufac-
turer’s instructions. Triplicate cycle threshold (Ct)
values were obtained for each sample and averaged for
evaluation. The 2
-ΔΔCt method was then used to calcu-
late the relative expression of each gene [26]. GAPDH
was amplified for use as an internal control in the reac-
tion for normalization. The primer sequences are pre-
sented in Table 1. The primer for SIRT1 was the same
as that described for use in the RT-PCR.
Immunohistochemical staining
The NP cells were fixed with 4% paraformaldehyde in
PBS for 15 minutes at room temperature. The cells
were permeabilized with 0.2% Triton X-100 in PBS for
15 minutes and blocked with 1% BSA in PBS (blocking
buffer) for 30 minutes. After blocking, the cells were
incubated overnight at 4°C with rabbit polyclonal anti-
SIRT1 antibody (SA-427; Enzo Life Science, Plymouth
Meeting, PA, USA) and mouse polyclonal anti-b-actin
antibody (sc-47778; Santa Cruz Biotechnology, Santa
Cruz, CA, USA) at a dilution of 1:50. The cells were
then incubated with Alexa Fluor 555-conjugated anti-
rabbit secondary antibody (Invitrogen, Carlsbad, CA,
USA) and Alexa Fluor 488-conjugated anti-mouse sec-
ondary antibody (Invitrogen) at a dilution of 1:200 for
an additional 2 hours. The cells were stained with Pro-
long Gold anti-fade reagent with DAPI-special packa-
ging (Invitrogen) and observed using fluorescence
Table 1 Gene-specific primer sequences used in RT-PCR and quantitative real-time RT-PCR
Gene Primer sequence Accession number
SIRT1 Forward: 5’-GCC TCA CAT GCA AGC TCT AGT GAC-3’ GenBank:NM_012238
Reverse: 5’-TTC GAG GAT CTG TGC CAA TCA TAA-3’
Aggrecan Forward: 5’-CTA CCA GTG GAT CGG CCT GAA-3’ GenBank:NM_001135
Reverse: 5’-CGT GCC AGA TCA TCA CCA CA-3’
Sox9 Forward: 5’-GGA GAT GAA ATC TGT TCT GGG AAT G-3’ GenBank:NM_000346
Reverse: 5’-TGA AGG TTA ACT GCT GGT GTT CTG A-3’
Collagen type 2 Forward: 5’-AAG GTG CTT CTG GTC CTG CTG-3’ GenBank:NM_001844
Reverse: 5’-GGG ATT CCA TTA GCA CCA TCT TTG-3’
a2-Macroglobulin Forward: 5’-TGG CGA TCG TTG ATG TGA AGA-3’ GenBank:NM_000014.4
Reverse: 5’-CTG TCC GGC TCA CAT GGT TAG A-3’
Cytokeratin-18 Forward: 5’-AGG AGT ATG AGG CCC TGC TGA A-3’ GenBank:NM_000224.2
Reverse: 5’-TTG CAT GGA GTT GCT GCT GTC-3’
CD56 Forward: 5’-TTC AAA TGC ACA GGC CCT CA-3’ GenBank:NM_000615.5
Reverse: 5’-GTC TCA GAC ACC CAG GCT CTC A-3’
GAPDH Forward: 5’-GCA CCG TCA AGG CTG AGA AC-3’ GenBank:NM_002046
Reverse: 5’-TGG TGA AGA CGC CAG TGG A-3’
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; SIRT1, silent mating type information regulator 2 homolog 1.
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Germany).
Transfection of recombinant human SIRT1 into human
nucleus pulposus cells using Pro-DeliverIN™-protein
delivery reagent
Because the aim of the present study was to determine
the direct effect of SIRT1 on homeostasis of human NP
cells and to extrapolate possible clinical applications for
SIRT1, recombinant human SIRT1 (rhSIRT1) (S8446;
Sigma-Aldrich) was employed instead of SIRT1 encod-
ing gene or siRNA, to avoid ethical issues and technical
problems. A protein delivery reagent, Pro-DeliverIN™
(OZ Biosciences, Marseille Cedex, France), was used to
more efficiently transfer rhSIRT1 into NP cells. Pro-
DeliverIN™ is a formulation of lipids capable of captur-
ing proteins through electrostatic and hydrophobic
interactions for delivery into cells. The transfection effi-
ciency for NP cells with Pro-DeliverIN™ was measured
using rhSIRT1 labeled with the HiLyte Fluor™ 555
Labeling Kit-NH2 (Dojindo Molecular Technology,
Gaithersburg, MD, USA). A microscopic visual count
was performed to calculate the transfection efficiency of
rhSIRT1. Cells were plated into 12-well plates at a den-
sity of 1.0 × 10
5 cells/well and cultured at 37°C. After 3
days of preculture, 10 μl Pro-DeliverIN™ and 10 μM
labeled rhSIRT1 were mixed in a microtube and incu-
bated for 15 minutes at room temperature. This mixture
was then added to each well. The cells were incubated
with the complete media at 37°C for 3 hours.
SDS-PAGE and western blot procedure
SIRT1 is known to deacetylate p53. The deacetylation
potential of transfected exogenous SIRT1 was investi-
gated by determining the protein expression of acety-
lated p53 using western blot analysis. For this
procedure, the exogenous fluorescent protein R-phy-
coerythrin, derived from cyanobacteria and eukayotic
algae, was employed as the negative control. The NP
cells transfected with 10 μM rhSIRT1 or R-phycoery-
thrin were lysed in MOPS buffer (25 mM Tris, 1% Noi-
det P40, 150 mM NaCl, 1.5 mM EGTA) supplemented
with a protease and phosphatase inhibitor mixture
(Roche Diagnostics, Basel, Switzerland) on ice for 20
minutes. The lysates were centrifuged at 19,000 × g to
remove cell debris, the supernatants were collected, and
3× electrophoresis sample buffer (Bio-Rad, Hercules,
CA, USA) was added and boiled for 5 minutes before
loading onto SDS-PAGE gels. The separated proteins
were transblotted onto the blotting membrane (Amer-
sham Biosciences, Arlington Heights, IL, USA). The
membranes were then probed with primary antibodies
followed by incubation with horseradish peroxidase-con-
jugated secondary antibody. Proteins were visualized
with ECL Plus reagent (Amersham Biosciences) using
the chemilumino analyzer LAS-3000 mini (FUJIFLIM).
Band intensities were quantified utilizing the image ana-
lysis software Image J version (NIH image; National
Institutes of Health, Bethesda, MD, USA) [27]. The anti-
bodies used in this study were rabbit anti-human acety-
lated p53 (Lys382) antibody (#2525S; Cell Signaling
Technology, Beverly, MA, USA), rabbit anti-human p53
antibody (#9282S; Cell Signaling Technology), anti-
mouse a-tubulin antibody (T9026; Sigma-Aldrich),
horseradish peroxidase-conjugated goat anti-rabbit IgG
and horseradish peroxidase-conjugated goat anti-mouse
IgG (Amersham Biosciences).
Effect of exogenous SIRT1 on the extracellular matrix
metabolism of human nucleus pulposus cells
To investigate the effect of exogenous SIRT1 on the
extracellular matrix metabolism of human NP cells, we
transferred rhSIRT1 and the negative control, R-phy-
coerythrin, into human NP cells. After 3 days of precul-
ture, the samples were cultured for 3 days with rhSIRT1
(0, 10 or 100 μM) or R-phycoerythrin (10 μM) in com-
plete media and Pro-DeliverIN™ with the manufac-
turer’s instructions. Total RNA was then isolated and
real-time RT-PCR analysis was performed to evaluate
the relative mRNA expression of the anabolic factors:
aggrecan, Sox9, collagen type 2 and GAPDH.
Effect of exogenous SIRT1 on cell proliferation
To examine the effect of exogenous SIRT1, cell prolif-
eration activity was measured with the WST-8 assay
using the Cell Counting Kit-8 (Dojindo Molecular Tech-
nology) following the manufacturer’s instructions. The
WST-8 assay is a colorimetric method in which the
amount of dye generated by the activity of dehydro-
genases in cells is measured. Cells from the 11 disc tis-
sues were plated into 96-well plates (1 × 10
4 cells/well)
and cultured in 5% carbon dioxide and 95% air at 37°C
in the complete tissue culture media described above.
After 3 days of preculture, rhSIRT1 (0, 10 or 100 μM)
or R-phycoerythrin (10 μM) with 1 μl Pro-DeliverIN™
was added to each well. After 3 days of treatment, the
number of treated NP cells in each well was calculated.
Briefly, 10 μl Cell Counting Kit-8 solution was added,
and the plate was incubated at 37°C for 2 hours. Absor-
bance at 450 nm was measured using a plate reader
(Bio-Rad). The proliferative activity of the cells in each
well was normalized by the cell number counted using a
microscope.
Statistical analyses
Analyses of the effects of donor age, disease and MRI
grade of degeneration were assessed using the Kruskal-
Wallis test. The correlation between the mRNA
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mined using the Spearman rank correlation test. Com-
parisons of the expression levels of SIRT1 mRNA
among the diseases or MRI grades were analyzed using
the Kruskal-Wallis test with a post hoc test. The effects
of rhSIRT1 evaluated by changes in mRNA expression
levels were assessed using the Kruskal-Wallis test with a
post hoc test. Post hoc analysis was performed with the
Mann-Whitney U test. All statistical analyses were per-
formed using JMP 8 (SAS Institute, Cary, NC, USA).
Statistical significance was accepted at P< 0.05.
Results
The analysis of donor age, disease class and the Pfirr-
mann disc degeneration grade found that the idiopathic
scoliosis patients were significantly younger than the
LDH and LSS patients, and their IVDs were categorized
as grade 2 disc degeneration (mean ± standard deviation
a g eb yd i s cg r a d e :g r a d e2 ,1 4 . 4±0 . 9y e a r s ;g r a d e3 ,
58.8 ± 12.0 years; grade 4, 54.4 ± 16.4 years; P <0 . 0 1 ) .
LDH and LSS patients were similar in age and disc
degeneration grade, with no significant differences seen
in age or Pfirrmann grade 3 and grade 4 disc degenera-
tion groups.
The maintenance of the character of NP cells was
confirmed by data establishing that the mRNA expres-
sion of a2-macroglobulin, cytokeratin-18, and CD56 was
maintained at the level of expression found in the pri-
mary culture (data not shown) [25].
SIRT1 mRNA and protein expression in nucleus pulposus
cells
RT-PCR analysis showed that SIRT1 mRNA was
expressed in the NP cells of all donors, with expression
levels varying with age (Figure 1a). In patients with idio-
pathic scoliosis, LDH and LSS, immunohistochemical
staining confirmed SIRT1 expression and nuclear locali-
zation with b-actin localized in the cytoplasm (Figure
1b). Real-time RT-PCR results showed that SIRT1
mRNA expression had a significant positive correlation
with age (P <0 . 0 5 ,r = 0.492) (Figure 2a). There was no
significant difference in SIRT1 mRNA expression
between male and female patients (data not shown).
When comparing MRI grades of all samples among the
Figure 1 SIRT1 mRNA and protein expression in nucleus pulposus cells. (a)Silent mating type information regulator 2 homolog 1 (SIRT1)
mRNA expression in human nucleus pulposus (NP) cells. Results of RT-PCR on NP cells derived from disc tissues of patients with lumbar spinal
stenosis, lumbar disc herniation and idiopathic scoliosis are shown. (b) SIRT1 protein distribution in NP cells. Immunohistochemical staining of
NP cells for b-actin (A) and SIRT1 (B) (images are merged in C). Bars = 15 μm. GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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level of SIRT1 mRNA expression than the grade 2 and
grade 4 groups (P < 0.05) (Figure 2b). No significant dif-
ferences in SIRT1 mRNA expression were found among
the idiopathic scoliosis, LDH and LSS groups.
These results confirm that SIRT1 was present in NP
cells obtained from all donors at both the mRNA and
protein levels. Because SIRT1 mRNA expression
increased significantly with increasing age and was sig-
nificantly higher in the Pfirrmann grade 3 disc degenera-
tion group, we believe SIRT1 may play a role in aging
and age-related chronic disorders.
Recombinant human SIRT1 transfection into nucleus
pulposus cells
We transfected exogenous SIRT1 protein into NP cells
to assess the function of SIRT1 in those cells. We first
determined that rhSIRT1 was effectively transfected into
NP cells by Pro-DeliverIN™ and retained its potential
to deacetylate p53. Immunohistochemical staining for
rhSIRT1 protein labeled with HiLyte Fluor™ 555
showed that rhSIRT1 was effectively transfected into NP
cells with a transfection efficacy of 37.9%. The morphol-
ogy of transfected NP cells was not changed, and the
number of NP cells was not altered by transfection with
rhSIRT1 (Figure 3a). Western blot revealed that
transfected rhSIRT1 deacetylated p53 and did not affect
total p53 and a-tubulin in NP cells (Figure 3b). The
negative control protein, R-phycoerythrin, did not affect
the expression levels of acetylated p53, total p53 and a-
tubulin. Furthermore, the potential of rhSIRT1 to deace-
tylate p53 was confirmed by western blot analysis of
three samples from idiopathic scoliosis, LDH and LSS
patients (data not shown).
Effect of exogenous SIRT1 on the extracellular matrix
metabolism of nucleus pulposus cells
To investigate the effect of exogenous SIRT1 on the
extracellular matrix metabolism of NP cells, real-time
RT-PCR analysis showed that SIRT1 treatment at 10
μM and 100 μM significantly decreased aggrecan and
Sox9 mRNA expression in a dose-dependent manner,
compared with both the control group and the negative
control group (mean values vs. control: aggrecan 10 μM,
-55.6% and 100 μM, -67%; and Sox9 10 μM, -35.3% and
100 μM, -41.3%) (Figure 4a, b, c). In addition, only 100
μM SIRT1 treatment significantly suppressed mRNA
expression of collagen type 2 (mean values vs. control:
100 μM, -72.7%). The negative control, R-phycoerythrin,
did not affect mRNA expression of aggrecan, Sox9 or
collagen type 2. This anti-anabolic effect of exogenous
SIRT1 was seen in all ages and disease classes. The
Figure 2 Correlation between SIRT1 mRNA expression, donor age, and Pfirrmann degeneration grade. (a) Correlation between mRNA
expression of silent mating type information regulator 2 homolog 1 (SIRT1) and donor age in nucleus pulposus cells derived from the disc tissues
of 19 patients with lumbar spinal stenosis, lumbar disc herniation, or idiopathic scoliosis. (b) Relationship of SIRT1 mRNA expression with the
Pfirrmann intervertebral disc degeneration grade from magnetic resonance imaging (MRI). *P< 0.05. GAPDH, glyceraldehyde 3-phosphate
dehydrogenase.
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grades, genders and disease classes showed no signifi-
cant differences and represented the same anti-anabolic
effect in ECM metabolism.
Effect of SIRT1 on the proliferation activity of nucleus
pulposus cells
The basal number of NP cells from LDH and LSS MRI
grade 3 and grade 4 discs was significantly higher than
that from idiopathic scoliosis MRI grade 2 discs. Treat-
ment with both 10 μM and 100 μMS I R T 1s i g n i f i c a n t l y
decreased the number of NP cells dose-dependently in
overall samples, compared with the control and negative
control groups (total: 10 μM, -34.4% and 100 μM,
-40.4% (Figure 5a); LDH and LSS: 10 μM, -21.5% and
100 μM, -34.4% (Figure 5b); and idiopathic scoliosis: 10
μM, -32.3% and 100 μM, -41.5% (Figure 5c); P < 0.05).
The values from the WST-8 assay of overall samples
were significantly (P < 0.05) decreased by both 10 μM
and 100 μM SIRT1 treatments (data not shown). To
demonstrate the activity of individual cells, we normal-
ized the values from the WST-8 assay to the cell
number in each well, and defined this as normalized
proliferation activity. The normalized proliferation activ-
ity of overall samples was not affected by treatment with
SIRT1 compared with the control and negative control
groups (Figure 6a). The normalized proliferation activity
of LDH and LSS samples was significantly decreased by
both treatments of 10 μM and 100 μMS I R T 1( v s .c o n -
trol as percentage of control: 10 μM, -59.4% and 100
μM, -46.4%; both P < 0.01) (Figure 6b). In contrast, in
idiopathic scoliosis samples this anti-proliferation activ-
ity was reversed, with SIRT1 treatment significantly
upregulating the normalized proliferation activity (vs.
control as percentage of control: 10 μM, +37.5% (P <
0.05) and 100 μM, +60.6% (P < 0.01)) (Figure 6c). The
negative control, R-phycoerythin, did not affect either
t h en u m b e ro rn o r m a l i z e dp r o liferation activity of NP
cells.
Discussion
Our study demonstrates for the first time that SIRT1 is
expressed by human NP cells. Almost all NP cells
express SIRT1 protein regardless of donor age.
Figure 3 Recombinant human SIRT1 transfection into nucleus pulposus cells. Transfection of recombinant human silent mating type
information regulator 2 homolog 1 (rhSIRT1) labeled with HiLyte Fluor™ 555 by Pro-DeliverIN™ into human nucleus pulposus (NP) cells. (a)
Immunohistochemical staining for SIRT1, b-actin and the nucleus (4’,6-diamidino-2-phenylindole). Red fluorescence shows labeled rhSIRT1 and
green fluorescence shows b-actin. Arrows show labeled rhSIRT1. Of the NP cells, 37.9% were transfected with labeled rhSIRT1. Bars = 20 μm. (b)
Western blot analysis for acetylated p53 and total p53. Western blot analysis confirmed that transfected SIRT1 deacetylated p53.
Zhang et al. Arthritis Research & Therapy 2011, 13:R200
http://arthritis-research.com/content/13/6/R200
Page 7 of 12Furthermore, SIRT1 mRNA expression levels signifi-
cantly increased with advancing age. It has been sug-
gested that the effects of SIRT1 vary during cellular
events. SIRT1 can regulate endothelial nitric oxide to
protect against cardiovascular disease, exert a cardiopro-
tective role in heart failure [28], and protect against
neurodegenerative pathological changes [17]. Although
SIRT1 does not always play a positive role in a variety
of physiological processes and pathophysiology, Li and
colleagues found that SIRT1 inhibition increased the
resistance of mammalian cells to oxidative stress [29].
SIRT1 also enhanced neural survival in acute anoxic
injury and provided neural protection [30,31].
Conflicting findings on the effects of SIRT1 have been
reported and the functions of SIRT1 are still unclear.
The function of SIRT1 in the homeostasis of human
IVD tissues has also not been clarified. A few investiga-
tors have reported the function of SIRT1 in articular
chondrocytes. Takayama and colleagues determined that
SIRT1 regulated apoptosis in human chondrocytes
through modulation of mitochondria-related apoptotic
signals [20]. Dvir-Ginzberg and colleagues found that
elevation of SIRT1 protein levels in human chondro-
cytes led to a dramatic increase in the cartilage-specific
gene expression of aggrecan, collagen type 2 and col-
lagen type 9, while a reduction in SIRT1 levels or activ-
ity significantly lowered the expression of these genes
[22]. These two reports suggest that SIRT1 plays a posi-
tive role in the maintenance of chondrocyte homeosta-
sis, the loss of which may lead to the development of
osteoarthritis [32]. In our study, however, SIRT1 treat-
ment significantly decreased the expression of aggrecan,
Sox9 and collagen type 2 mRNA and the proliferation
activity was downregulated in degenerated IVD tissues.
Transfection with rhSIRT1 thus seemed to have no
positive effect on anabolism. This difference in function
Figure 4 Effect of exogenous SIRT1 on the extracellular matrix metabolism of nucleus pulposus cells. mRNA expression of (a) aggrecan,
(b) Sox9 and (c) collagen type 2 following treatment with recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1).
Data were obtained from 11 patients (six lumbar spinal stenosis and lumbar disc herniation patients, and five idiopathic scoliosis patients).
GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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Page 8 of 12Figure 5 Effect of SIRT1 on the number of nucleus pulposus cells. The number of human nucleus pulposus cells following treatment with
recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1). (a) Total samples (n = 11). (b) Lumbar spinal stenosis and
lumbar disc herniation (n = 6). (c) Idiopathic scoliosis (n = 5).
Figure 6 Effect of SIRT1 on the proliferation activity of nucleus pulposus cells. The normalized proliferation activity following treatment
with recombinant human silent mating type information regulator 2 homolog 1 (rhSIRT1). (a) Total samples (n = 11). (b) Lumbar spinal stenosis
and lumbar disc herniation (n = 6). (c) Idiopathic scoliosis (n = 5).
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to differences in the Pasteur effect in articular chondro-
cytes and IVD cells. While glucose is the main energy
resource for both articular chondrocytes and NP cells,
these cells differ in glucose metabolism under anoxic
stress. Under aerobic conditions, articular cartilage cells
s h o wan e g a t i v eP a s t e u re f f e c t ,b u tu n d e ra n o x i cc o n d i -
tions both glucose uptake and lactate production are
greatly inhibited [33]. IVD cells, on the other hand,
show a positive progressive Pasteur effect [34]. Under
lowered oxygen conditions, IVD cells show reduced oxy-
gen consumption but increased lactate production. The
metabolism of NP cells depends primarily on glycolysis,
unlike articular chondrocytes. Consequently, NP cells
are rich in NAD
+ produced by glycolysis [35]. Increased
NAD
+ levels may accelerate the NAD
+-dependent dea-
cetylase function of SIRT1. The difference in NAD
+ pro-
duction may explain the different functioning of SIRT1
in articular chondrocytes and IVD cells.
In our study, SIRT1 mRNA expression showed different
trends in aging and degeneration. SIRT1 mRNA expres-
sion was significantly higher with increasing age, whereas
NP cells from MRI grade 3 degeneration discs had higher
SIRT1 mRNA expression than did grades 2 and 4.
Although the pathomechanism of disc degeneration
remains unclear, no relationship between age and macro-
scopic IVD degeneration was found in a postmortem
study of 273 cadavers [36]. Sowa and colleagues reported
finding different gene expressions of NP cells between
aging and degeneration in their rabbit model [37]. If
SIRT1 is one of the constitutive inducers of human IVD
degeneration, grade 4 degeneration discs should show
stronger SIRT1 mRNA expression than lower grade discs.
Kauppila used angiograms of cadaveric lumbar spines
to show that vascular changes occurred prior to disc
degeneration and that disturbance in the nutrient supply
preceded early disc degeneration [38]. Miller and collea-
gues stated that mechanical stress and the nutrition
p a t h w a yw e r er e s p o n s i b l ef o r early disc degeneration
found in their study [36]. From these reports, the dete-
rioration of the internal environment of IVD tissues,
caused by disturbance of the nutrient supply, was
thought to progressively decrease synthesis, leading the
IVD into early stages of degeneration. As discussed
above, calorie restriction is thought to be a strong indu-
cer of SIRT1 protein expression in humans and rodents
[23]. SIRT1 might be induced in the early disc degenera-
tion stage when the disc internal environment begins to
deteriorate from a disturbance in the nutrient supply.
The deterioration of the internal environment prior to
early disc degeneration may thus induce SIRT1 expres-
sion. The decreasing oxygen tension in advanced IVD
degeneration may also affect the function of SIRT1 on
proliferation activity by a positive Pasteur effect.
The adequacy of the nutrition supply is also depen-
dent on cell activity. Masuda and colleagues have stated
that proliferating cells stimulated by growth factors
require more nutrition [39]. Unless the nutrition supply
is adequate to support their activity, proliferating cells
die [39]. Indeed, increased IVD cell proliferation and
density are so commonly seen around a tissue cleft in
degenerative discs that one may assume neovasculariza-
tion contributes to improving the nutrition supply and
stimulating cell proliferation in areas adjacent to the
newly formed blood vessels. Consequently, increased
cell proliferation has been used as an indicator for disc
degeneration [6,40]. Furthermore, Boos and colleagues
reported that cell death was increased in degenerated
discs [41] and apoptosis was recently reported to play
an important role in disc degeneration [42]. Adaptation
to the deteriorating internal environment associated
with inadequate nutrient supply may possibly reduce the
anabolic activity, cell number and proliferative activity
of NP cells.
Based on our results, especially the finding that the
effect of SIRT1 on proliferation activity is altered by
advanced IVD degeneration, the authors postulate that
SIRT1 plays a role in the maintenance of IVD tissue
h o m e o s t a s i s .N a m e l y ,S I R T 1p l a y sap o s i t i v er o l ef o r
IVD proliferation in MRI grade 2 discs and is then upre-
gulated in grade 3 discs, where its role seems to be to
suppress ECM metabolism and proliferation activity in
IVD tissues after grade 3 degeneration. SIRT1 might
therefore be upregulated at an early stage of degenera-
tion, causing NP cells to downregulate both anabolic
and proliferation activity, thus helping NP cells survive
the deteriorating internal environment resulting from
preceding vascular changes. SIRT1 was initially upregu-
lated to adapt to deteriorating internal circumstance in
early degeneration, but the failure of NP cells to adapt
resulted in decreased SIRT1 mRNA expression in
advanced degeneration.
In the present study, the samples were obtained from
patients but cultured under normal conditions (5% car-
bon dioxide, rich nutrition and normal pH), different
from the in vivo environment. Consequently, our results
may reflect the function of SIRT1 under the culture
conditions compared with the limited in vivo environ-
ment in which the tissues exist. Further research is
needed to elucidate the function of SIRT1 in human
IVD degeneration.
Conclusions
We have demonstrated that SIRT1 is expressed by
human NP cells. SIRT1 mRNA expression increased sig-
nificantly with donor age and was seen most strongly in
early grade 3 disc degeneration. Treatment with exogen-
ous SIRT1 reduced anabolic activity in NP cells. In
Zhang et al. Arthritis Research & Therapy 2011, 13:R200
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Page 10 of 12addition, proliferation activity was upregulated by SIRT1
treatment in idiopathic scoliosis samples with relatively
nondegenerated tissues, and was downregulated in LDH
and LSS samples with more degenerated IVD tissues.
These results are interpreted to indicate that SIRT1 par-
ticipates in the degenerative changes in extracellular
matrix metabolism as an early responder to IVD degen-
eration rather than a constitutive inducer of it. SIRT1
may be upregulated to induce the downregulation of
anabolic and proliferation activity of NP cells to aid sur-
vival in the deterioration of the disc environment arising
from preceding vascular changes. We suggest that
SIRT1 may play a key role in the early stage of disc
degeneration in human IVD tissues. The study of SIRT1
function in NP cells may lead to new approaches to
study the pathomechanism of IVD degeneration.
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